230 related articles for article (PubMed ID: 19125898)
21. Personality influences the reporting of side effects of inhaled corticosteroids in asthma patients.
Foster JM; Sanderman R; van der Molen T; Mueller T; van Sonderen E
J Asthma; 2008 Oct; 45(8):664-9. PubMed ID: 18951257
[TBL] [Abstract][Full Text] [Related]
22. The efficacy and safety of mometasone furoate delivered via a dry powder inhaler for the treatment of asthma.
Meltzer EO; Wenzel S
J Asthma; 2006 Dec; 43(10):765-72. PubMed ID: 17169829
[TBL] [Abstract][Full Text] [Related]
23. Inhaled corticosteroids in obstructive airway disease.
Phua GC; Macintyre NR
Respir Care; 2007 Jul; 52(7):852-8. PubMed ID: 17594729
[TBL] [Abstract][Full Text] [Related]
24. Ciclesonide: A Pro-Soft Drug Approach for Mitigation of Side Effects of Inhaled Corticosteroids.
Mukker JK; Singh RSP; Derendorf H
J Pharm Sci; 2016 Sep; 105(9):2509-2514. PubMed ID: 27339407
[TBL] [Abstract][Full Text] [Related]
25. New developments in corticosteroids.
Hochhaus G
Proc Am Thorac Soc; 2004; 1(3):269-74. PubMed ID: 16113445
[TBL] [Abstract][Full Text] [Related]
26. Advances in single-entity inhaled corticosteroid therapy.
Tayab ZR; Hochhaus G
Allergy Asthma Proc; 2007; 28(2):125-35. PubMed ID: 17479595
[TBL] [Abstract][Full Text] [Related]
27. Safety of inhaled corticosteroids: room for improvement.
Rossi GA; Cerasoli F; Cazzola M
Pulm Pharmacol Ther; 2007; 20(1):23-35. PubMed ID: 16359896
[TBL] [Abstract][Full Text] [Related]
28. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
Kopriva F; Dzubak P; Potesil J; Hajduch M
J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
[TBL] [Abstract][Full Text] [Related]
29. Effect of intermittent systemic corticosteroid on bone metabolism in bronchial asthma patients.
Mori H; Tanaka H; Ohno Y; Ito F; Funaguchi N; Endo J; La BL; Minatoguchi S
J Asthma; 2009 Mar; 46(2):142-6. PubMed ID: 19253119
[TBL] [Abstract][Full Text] [Related]
30. Evidence-based selection of inhaled corticosteroid for treatment of chronic asthma.
Abdullah AK; Khan S
J Asthma; 2007; 44(1):1-12. PubMed ID: 17365197
[TBL] [Abstract][Full Text] [Related]
31. Aseptic femoral head necrosis in a patient receiving long term courses of inhaled and intranasal corticosteroids.
Karkoulias K; Charokopos N; Kaparianos A; Sampsonas F; Tsiamita M; Spiropoulos K
Tuberk Toraks; 2007; 55(2):182-5. PubMed ID: 17602347
[TBL] [Abstract][Full Text] [Related]
32. Potential adverse effects of the inhaled corticosteroids.
Kelly HW; Nelson HS
J Allergy Clin Immunol; 2003 Sep; 112(3):469-78; quiz 479. PubMed ID: 13679801
[TBL] [Abstract][Full Text] [Related]
33. Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective.
Rohatagi S; Appajosyula S; Derendorf H; Szefler S; Nave R; Zech K; Banerji D
J Clin Pharmacol; 2004 Jan; 44(1):37-47. PubMed ID: 14681340
[TBL] [Abstract][Full Text] [Related]
34. Perception of the role of inhaled corticosteroids and factors affecting compliance among asthmatic adult patients.
Al-Jahdali HH; Al-Zahrani AI; Al-Otaibi ST; Hassan IS; Al-Moamary MS; Al-Duhaim AS; Al-Shimemeri AA; Al-Dawood AS
Saudi Med J; 2007 Apr; 28(4):569-73. PubMed ID: 17457479
[TBL] [Abstract][Full Text] [Related]
35. Inhaled corticosteroid-related tooth problems in asthmatics.
Han ER; Choi IS; Kim HK; Kang YW; Park JG; Lim JR; Seo JH; Choi JH
J Asthma; 2009 Mar; 46(2):160-4. PubMed ID: 19253123
[TBL] [Abstract][Full Text] [Related]
36. How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids.
Winkler J; Hochhaus G; Derendorf H
Proc Am Thorac Soc; 2004; 1(4):356-63. PubMed ID: 16113458
[TBL] [Abstract][Full Text] [Related]
37. Intranasal corticosteroids and adrenal suppression.
Bruni FM; De Luca G; Venturoli V; Boner AL
Neuroimmunomodulation; 2009; 16(5):353-62. PubMed ID: 19571596
[TBL] [Abstract][Full Text] [Related]
38. New developments in inhaled corticosteroids.
Colice GL
Allergy Asthma Proc; 2006; 27(5):332-40. PubMed ID: 17063660
[TBL] [Abstract][Full Text] [Related]
39. Practical considerations for dysphonia caused by inhaled corticosteroids.
Galván CA; Guarderas JC
Mayo Clin Proc; 2012 Sep; 87(9):901-4. PubMed ID: 22958993
[TBL] [Abstract][Full Text] [Related]
40. Influence of inhaler systems on systemic availability, with focus on inhaled corticosteroids.
Thorsson L
J Aerosol Med; 1995 Sep; 8 Suppl 3():S29-36; discussion S37. PubMed ID: 10157896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
